Ezra, the healthcare AI startup transforming early cancer detection through full body MRI screening, today launched a new partnership with AMRIC Health, a precision imaging clinic located in New York City’s Upper East Side neighborhood. Combining AMRIC’s state-of-the-art imaging equipment with Ezra’s AI-powered whole-body MRI screening technology will help more people in the New York City metro area proactively monitor and manage their health, identifying disease and cancer as early as possible.
More than 1.9 million people will be diagnosed with cancer in the U.S. in 2024, and half of them will be diagnosed late. Because cancer is most curable when detected early, Ezra’s technology is focused on improving the accuracy and speed of the MRI process without compromising quality results. Ezra’s proprietary AI brings added efficiency to key components of the cancer screening process, including imaging, analysis and reporting, and direct-to-consumer communication – allowing for scans to be completed in just 30 minutes and costing less for consumers.
AMRIC Health’s approach in the Upper East Side of New York City plays a critical role in contributing to the well-being and health outcomes of its patients. AMRIC offers personalized care, advanced technology, and a patient-centered experience that aligns with the community’s values, ultimately leading to improved health outcomes and a positive impact on individual lives. As Ezra’s most advanced facility yet, AMRIC Health offers access to 3T MRI machines with 75cm openings (the widest on the market), alongside music, lighting, and video to create a more enjoyable MRI experience. AMRIC Health boasts some of the best technologists nationwide, ensuring Ezra customers can find potential disease as quickly as possible.
“At AMRIC, we recognize the significance of technology and the pivotal role of early disease detection in effective healthcare,” said Dr. Omer Aras, co-founder of Amric Health. “Working with Ezra will allow us to continue pushing for early intervention and management of disease, increasing the likelihood of successful treatment and illness prevention for our patients. We’re committed to using innovation to create better healthcare outcomes, and this collaboration is a reflection of how we’ll do it.”
“I created Ezra to help more people identify and treat cancer as early as possible, so they have a better chance of survival,” said Emi Gal, founder and CEO of Ezra. “Our widening footprint and new partnerships – including this one with AMRIC Health – shows just how many individuals we’re able to reach, ensuring they have access to technology that can proactively address cancer and disease before it’s too late to cure.”
